Neonatal saliva and urine exosomes as non-invasive biomarkers for neonatal outcomes in preterm infants

Brief description of study

The purpose of this study is to evaluate if biomarkers measured in body fluids (such as saliva, urine, and blood) and stool samples are associated with distinct neonatal diseases such as chronic lung disease of prematurity. Biomarkers are a measurable substance in body fluid that can predict the occurrence of a specific outcome, in this case, it will complications of prematurity such as lung disease. This is significant because findings could revolutionize the way preterm infants in neonatal intensive care units (NICUs) are monitored at the bedside.

Clinical Study Identifier: s19-01825
Principal Investigator: Nazeeh N Hanna.

If you are registered as a volunteer, please log in to contact the study team/express interest in this study.

Contact the research team to learn more about this study.

By clicking "Contact Research Team", your contact information will be sent securely to the research staff associated with the study. You will also receive a copy of this email in your inbox, as well as other notifications to determine your participation status in the study.